CODX vs SBUX · rev $3.9M vs P/E 76, rev $37.18B
Co-Diagnostics, Inc. Common Stock (CODX) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
CODX currently screens at market cap $31.4M. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the CODX and SBUX stock pages for the full models.
Not investment advice.